Please Wait.....
Report
United Kingdom Veterinary Healthcare - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026 - 2031)
Market Report I 2026-02-09 I 120 Pages I Mordor Intelligence
United Kingdom Veterinary Healthcare Market Analysis
The United Kingdom veterinary healthcare market was valued at USD 3.38 billion in 2025 and estimated to grow from USD 3.63 billion in 2026 to reach USD 5.17 billion by 2031, at a CAGR of 7.38% during the forecast period (2026-2031). Companion animal ownership has risen to 60% of households, a structural demand driver that cushions the market against Brexit-related supply realignments. Consolidation among practice groups strengthens purchasing power and accelerates technology adoption, yet it intensifies regulatory scrutiny aimed at protecting consumer choice. Rapid upgrades in point-of-care testing, artificial intelligence (AI) diagnostics and long-acting parasiticides elevate clinical standards while widening revenue streams for practices. Meanwhile, livestock operators expand biosecurity programs in response to repeated H5N1 alerts, anchoring steady volumes for vaccines and surveillance services.
United Kingdom Veterinary Healthcare Market Trends and Insights
Technological Advancements In Veterinary Therapeutics and Diagnostics
AI-enabled platforms such as Zoetis' Vetscan Imagyst now provide on-site cytology in minutes, freeing scarce clinicians for higher-value tasks and reducing diagnostic error rates. Portable infrared thermography and wearable sensors extend continuous monitoring for livestock, triggering early alerts that curb herd-level losses. Integrated telemedicine portals tethered to in-clinic devices foster hybrid workflows that expand reach into rural communities. IDEXX's inVue analyzer shows how modular chemistry, hematology and urinalysis stations compress full laboratory capability into countertop space, enabling same-visit treatment decisions. Long-acting parasiticides such as MSD's BRAVECTO chewable extend dose intervals to 12 weeks, reinforcing owner compliance while moderating antimicrobial use.
Growing Companion Animal Ownership and Expenditure
Seventeen-point-two million UK households housed a pet in 2024, with the dog and cat population growing by 1.5 million annually. Owners treat animals as family members, elevating demand for oncology, orthopedic and behavioral services once confined to human medicine. Men now account for 27% of adult-cat adoptions versus 18% for women, shifting product and service preferences toward technology-driven convenience. Aged pets require chronic disease management, extending lifetime spend per animal. Emotional capital forged during pandemic lockdowns sustains willingness to finance premium diagnostics, fueling revenue beyond pure volume growth.
Escalating Cost of Veterinary Services and Products
Average veterinary invoices have climbed 60% since 2014, amplifying affordability barriers that push some owners to postpone treatments. The Dogs Trust reports clients weighing elective care against budget constraints, signaling elastic demand that could temper overall growth. Forty percent of clinic employees say revenue targets sway clinical decisions, fueling CMA scrutiny. IDEXX noted a 2.1% dip in visit frequency in 2024 despite value gains, highlighting price sensitivity in preventive care segments.
Other drivers and restraints analyzed in the detailed report include:
Rising Livestock Health Management Needs Amid Zoonotic RisksExpansion Of Corporate Veterinary Practice NetworksLimited Availability of Skilled Veterinary Professionals
For complete list of drivers and restraints, kindly check the Table Of Contents.
Segment Analysis
Therapeutics generated 59.78% of United Kingdom veterinary healthcare market share in 2025, reflecting entrenched demand for vaccines, parasiticides and anti-infectives. Diagnostics is growing at a 7.59% CAGR as point-of-care devices and AI analytics shorten the path from sample to therapy. Immunodiagnostics dominate revenue today, while molecular assays scale rapidly for resistance profiling. Portable ultrasound and digital radiography embed in primary care, replacing referrals and unlocking ancillary fees. Within therapeutics, vaccine uptake accelerates on heightened biosecurity awareness, whereas antimicrobial-laden feed additives face regulatory headwinds, nudging manufacturers toward precision nutrition alternatives.
Investment in diagnostics aligns with evidence-based protocols that lower drug overuse and improve outcomes, further anchoring recurring consumables revenue. AI platforms classify cytology slides in under eight minutes, enabling same-day oncology interventions. As practice groups aggregate, bulk procurement of analyzers lowers per-test costs, widening access to advanced assays even in mid-tier clinics.
Dogs and cats accounted for 44.86% of United Kingdom veterinary healthcare market size in 2025, supported by 13.5 million dogs and 12.5 million cats needing routine, emergency and specialty care. Poultry is projected to expand at an 7.93% CAGR as stringent avian influenza surveillance heightens veterinary oversight across commercial flocks. Equine demand remains stable, fueled by sports and leisure riding, while ruminant health programs gain traction under climate-adaptation pressures. Swine operators adopt modern traceability, yet African swine fever vigilance keeps veterinary certification volumes high.
Pet humanization drives uptake of chemotherapy, MRI scans and behavioral therapies, elevating average spend per visit. Poultry producers embed veterinarians in biosecurity governance, reducing downtime costs from disease outbreaks. Cross-species H5N1 transmission to sheep in 2024 underlines growing need for multi-species surveillance frameworks.
The United Kingdom Veterinary Healthcare Market Report is Segmented by Product (Therapeutics and Diagnostics), Animal Type (Dogs & Cats, Horses, and More), Route of Administration (Oral, Parenteral, Topical, and Other Route of Administrations), and End User (Veterinary Hospitals & Clinics, and More). The Market Forecasts are Provided in Terms of Value (USD).
List of Companies Covered in this Report:
Zoetis MSD Animal Health Boehringer Ingelheim Elanco Virbac Vetoquinol Ceva Sante Animale Covetrus ECO Animal Health Group KRKA UK TVM UK Dechra Pharmaceuticals Pets at Home Vet Group CVS Group plc IDEXX Norbrook Laboratories Parnell Pharma Abaxis UK (Zoetis) Henry Schein Animal Health MiLab (Lab Services)
Additional Benefits:
The market estimate (ME) sheet in Excel format
3 months of analyst support
1 Introduction
1.1 Study Assumptions & Market Definition
1.2 Scope of the Study
2 Research Methodology
3 Executive Summary
4 Market Landscape
4.1 Market Overview
4.2 Market Drivers
4.2.1 Technological Advancements in Veterinary Therapeutics and Diagnostics
4.2.2 Growing Companion Animal Ownership and Expenditure
4.2.3 Rising Livestock Health Management Needs Amid Zoonotic Risks
4.2.4 Expansion of Corporate Veterinary Practice Networks
4.2.5 Increasing Adoption of Pet Insurance And Wellness Plans
4.2.6 Government and Regulatory Support for One-Health Initiatives
4.3 Market Restraints
4.3.1 Escalating Cost of Veterinary Services and Products
4.3.2 Limited Availability of Skilled Veterinary Professionals
4.3.3 Prevalence of Counterfeit and Sub-Standard Medicines
4.3.4 Market Consolidation Impacting Supplier Bargaining Power
4.4 Regulatory Landscape
4.5 Porter's Five Forces Analysis
4.5.1 Bargaining Power Of Suppliers
4.5.2 Bargaining Power Of Buyers/Consumers
4.5.3 Threat Of New Entrants
4.5.4 Threat Of Substitute Products
4.5.5 Intensity Of Competitive Rivalry
5 Market Size & Growth Forecasts (Value, USD)
5.1 By Product
5.1.1 Therapeutics
5.1.1.1 Vaccines
5.1.1.2 Parasiticides
5.1.1.3 Anti-Infectives
5.1.1.4 Medical Feed Additives
5.1.1.5 Other Therapeutics
5.1.2 Diagnostics
5.1.2.1 Immunodiagnostic Tests
5.1.2.2 Molecular Diagnostics
5.1.2.3 Diagnostic Imaging
5.1.2.4 Clinical Chemistry
5.1.2.5 Other Diagnostics
5.2 By Animal Type
5.2.1 Dogs & Cats
5.2.2 Horses
5.2.3 Ruminants
5.2.4 Swine
5.2.5 Poultry
5.2.6 Other Animal Types
6 Market Size & Growth Forecasts (Value, USD)
6.1 By Product
6.1.1 Therapeutics
6.1.1.1 Vaccines
6.1.1.2 Parasiticides
6.1.1.3 Anti-Infectives
6.1.1.4 Medical Feed Additives
6.1.1.5 Other Therapeutics
6.1.2 Diagnostics
6.1.2.1 Immunodiagnostic Tests
6.1.2.2 Molecular Diagnostics
6.1.2.3 Diagnostic Imaging
6.1.2.4 Clinical Chemistry
6.1.2.5 Other Diagnostics
6.2 By Animal Type
6.2.1 Dogs & Cats
6.2.2 Horses
6.2.3 Ruminants
6.2.4 Swine
6.2.5 Poultry
6.2.6 Other Animal Types
6.3 By Route Of Administration
6.3.1 Oral
6.3.2 Parenteral
6.3.3 Topical
6.3.4 Other Route of Administrations
6.4 By End User
6.4.1 Veterinary Hospitals & Clinics
6.4.2 Reference Laboratories
6.4.3 Point-Of-Care / In-House Testing Settings
6.4.4 Academic & Research Institutes
7 Competitive Landscape
7.1 Market Concentration
7.2 Market Share Analysis
7.3 Company Profiles (includes Global level Overview, Market level overview, Core Segments, Financials as available, Strategic Information, Market Rank/Share, Products & Services, Recent Developments)
7.3.1 Zoetis Inc.
7.3.2 MSD Animal Health
7.3.3 Boehringer Ingelheim
7.3.4 Elanco Animal Health
7.3.5 Virbac Corporation
7.3.6 Vetoquinol
7.3.7 Ceva Sante Animale
7.3.8 Covetrus
7.3.9 ECO Animal Health Group
7.3.10 KRKA UK Ltd
7.3.11 TVM UK
7.3.12 Dechra Pharmaceuticals
7.3.13 Pets at Home Vet Group
7.3.14 CVS Group plc
7.3.15 IDEXX Laboratories
7.3.16 Norbrook Laboratories
7.3.17 Parnell Pharma
7.3.18 Abaxis UK (Zoetis)
7.3.19 Henry Schein Animal Health
7.3.20 MiLab (Lab Services)
8 Market Opportunities & Future Outlook
8.1 White-space & Unmet-need Assessment
- Not Sure / Need Reassuring
- Confirm Content
-
Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:
Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.
Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.
Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.
-
- Sample Pages
-
With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.
It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.
To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Check for Alternatives
-
Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.
To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.
-
- Confirm Content
- Prices / Formats / Delivery
- Prices
-
All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.
Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Discounts
-
As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.
Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.
To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Available Currencies
-
Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.
Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.
To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.
-
- Licenses
-
License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Global Site License
-
The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.
It is important to note that this may exclude Parent Companies or Subsidiaries.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Formats
-
The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.
If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.
-
- Delivery
-
Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.
Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.
If a delay in delivery is expected you will be informed about it immediately.
-
- Shipping Charges
-
As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.
If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.
-
- Prices
- Ordering
- By Credit Card
-
We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.
Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.
For more information on PayU please visit: https://www.payu.pl/en/about-us
-
- By Money Transfer
-
If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.
With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.
-
- By Credit Card
- Security
- Website security
-
We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.
Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.
-
- Credit Card Security
-
We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.
PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.
-
- Website security